77 related articles for article (PubMed ID: 2747971)
1. [Effect of chronic alcohol consumption on blood lipid levels and angiopathy in diabetics].
Bertello PD; Gurioli LZ; Gurioli LR; Magro E
Minerva Med; 1989 May; 80(5):443-6. PubMed ID: 2747971
[TBL] [Abstract][Full Text] [Related]
2. [Disorders of lipid metabolism in diabetes mellitus].
Biesenbach G
Wien Med Wochenschr Suppl; 1989; 105():9-17. PubMed ID: 2694631
[TBL] [Abstract][Full Text] [Related]
3. Plasma lipid profiles and vascular disease in type 2 (non-insulin dependent) Nigerian diabetic patients.
Agbedana EO; Akanji AO
Trop Geogr Med; 1988 Apr; 40(2):88-92. PubMed ID: 3407012
[TBL] [Abstract][Full Text] [Related]
4. [Effect of hyperlipoproteinemia on blood fibrinolytic activity and thrombocyte aggregation].
Kostić N; Secen S
Med Pregl; 2000; 53(3-4):180-3. PubMed ID: 10965685
[TBL] [Abstract][Full Text] [Related]
5. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
Oki JC
Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
[TBL] [Abstract][Full Text] [Related]
6. Implications of decreased serum adiponectin for type IIb hyperlipidaemia and increased cholesterol levels of very-low-density lipoprotein in type II diabetic patients.
Yoshida H; Hirowatari Y; Kurosawa H; Tada N
Clin Sci (Lond); 2005 Sep; 109(3):297-302. PubMed ID: 15907189
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
8. Effects of soybean D-LeciVita product on serum lipids and fatty acid composition in type 2 diabetic patients with hyperlipidemia.
Ristić Medić D; Ristić V; Arsić A; Postić M; Ristić G; Blazencić Mladenović V; Tepsić J
Nutr Metab Cardiovasc Dis; 2006 Sep; 16(6):395-404. PubMed ID: 16935698
[TBL] [Abstract][Full Text] [Related]
9. Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type II diabetes with nephropathy.
Azadbakht L; Shakerhosseini R; Atabak S; Jamshidian M; Mehrabi Y; Esmaill-Zadeh A
Eur J Clin Nutr; 2003 Oct; 57(10):1292-4. PubMed ID: 14506491
[TBL] [Abstract][Full Text] [Related]
10. Long-term (18-month) efficacy of atorvastatin therapy in type 2 diabetics at cardiovascular risk.
Velussi M
Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):29-35. PubMed ID: 12125227
[TBL] [Abstract][Full Text] [Related]
11. Low HDL-cholesterol is common in European Type 2 diabetic patients receiving treatment for dyslipidaemia: data from a pan-European survey.
Bruckert E; Baccara-Dinet M; Eschwege E
Diabet Med; 2007 Apr; 24(4):388-91. PubMed ID: 17335463
[TBL] [Abstract][Full Text] [Related]
12. [Lipid status in the physician's laboratory].
Drexel H
Ther Umsch; 1995 May; 52(5):340-2. PubMed ID: 7770820
[TBL] [Abstract][Full Text] [Related]
13. [HDL-cholesterol in diabetes mellitus. Analysis of type of diabetes, therapy, duration of disease and metabolic control (author's transl)].
Prager R; Schernthaner G; Müller MM
Wien Klin Wochenschr; 1980 Oct; 92(19):672-7. PubMed ID: 7008366
[TBL] [Abstract][Full Text] [Related]
14. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
Habib SS; Aslam M; Naveed AK; Razi MS
Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
[TBL] [Abstract][Full Text] [Related]
15. [Hemostasis and lipid metabolism in patients with non-insulin- dependent diabetes mellitus and angiopathy of the lower extremities].
Mamedgasanov RM; Semavin IE; Smirnova LM; Rudenko GR; Riazanov IuI
Klin Med (Mosk); 1989 Aug; 67(8):74-6. PubMed ID: 2811244
[TBL] [Abstract][Full Text] [Related]
16. Comparison of lipid levels, hyperlipidemia prevalence and its risk factors between Guangxi Hei Yi Zhuang and Han populations.
Yin R; Chen Y; Pan S; He F; Liu T; Yang D; Wu J; Yao L; Lin W; Li R; Huang J
Arch Med Res; 2006 Aug; 37(6):787-93. PubMed ID: 16824940
[TBL] [Abstract][Full Text] [Related]
17. Postprandial hypertriglyceridemia and carotid intima-media thickness in north Indian type 2 diabetic subjects.
Ahmad J; Hameed B; Das G; Siddiqui MA; Ahmad I
Diabetes Res Clin Pract; 2005 Aug; 69(2):142-50. PubMed ID: 15955588
[TBL] [Abstract][Full Text] [Related]
18. Lipid profile in patients with coronary artery disease.
Haddad FH; Omari AA; Shamailah QM; Malkawi OM; Shehab AI; Mudabber HK; Shubaki MK
Saudi Med J; 2002 Sep; 23(9):1054-8. PubMed ID: 12370711
[TBL] [Abstract][Full Text] [Related]
19. Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy.
Alghasham AA; Barakat YA
Saudi Med J; 2008 Feb; 29(2):185-92. PubMed ID: 18246224
[TBL] [Abstract][Full Text] [Related]
20. Analysis of serum lipids and lipoproteins in Ethiopian diabetic patients.
Seyoum B; Abdulkadir J; Berhanu P; Feleke Y; Mengistu Z; Worku Y; Ayana G
Ethiop Med J; 2003 Jan; 41(1):1-8. PubMed ID: 12764995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
